Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral May/19/2021 26 7
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Baicalein Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 6 0
Remdesivir Approved by FDA Experimental Antiviral Apr/21/2021 62 5
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/10/2021 35 4
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/09/2021 15 8
Ribavirin Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/25/2021 10 2
Heparin Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/22/2021 12 1
Low Molecular Weight Heparin Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/18/2021 6 1
Sofosbuvir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/18/2020 6 5